Concurrent chemoradiotherapy with tomotherapy in locally advanced non-small cell lung cancer: a phase i, docetaxel dose-escalation study, with hypofractionated radiation regimen

BACKGROUND: Concurrent chemo-radiotherapy is demonstrately superior to sequential chemo-radiotherapy in the treatment of advanced Non-Small-Cell Lung Cancer not suitable for surgery. Docetaxel is considered to enhance the cytotoxic effect of radiotherapy on the tumour cells. Tomotherapy (HT) is a no...

Descripción completa

Detalles Bibliográficos
Autores principales: Bearz, Alessandra, Minatel, Emilio, Rumeileh, Imad Abu, Borsatti, Eugenio, Talamini, Renato, Franchin, Giovanni, Gobitti, Carlo, Del Conte, Alessandro, Trovò, Marco, Baresic, Tanja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228391/
https://www.ncbi.nlm.nih.gov/pubmed/24176164
http://dx.doi.org/10.1186/1471-2407-13-513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228391/
https://www.ncbi.nlm.nih.gov/pubmed/24176164
http://dx.doi.org/10.1186/1471-2407-13-513

Ejemplares similares